Review



caix  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Novus Biologicals caix
    Summary of the immunocytochemical analysis of CNHCs with <t> antibodies </t> against CD45, CD31, and <t> CAIX </t>
    Caix, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 327 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/Carbonic+Anhydrase+IX%2FCA9+Antibody+-+BSA+Free/pmc03848446-186-9-13
    Average 96 stars, based on 327 article reviews
    caix - by Bioz Stars, 2026-11
    96/100 stars

    Images

    1) Product Images from "Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?"

    Article Title: Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?

    Journal: Journal of Translational Medicine

    doi: 10.1186/1479-5876-11-214

    Summary of the immunocytochemical analysis of CNHCs with  antibodies  against CD45, CD31, and  CAIX
    Figure Legend Snippet: Summary of the immunocytochemical analysis of CNHCs with antibodies against CD45, CD31, and CAIX

    Techniques Used:

    Immunocytochemical analysis of CNHCs with antibodies against the RCC marker CAIX. Clusters of CNHCs cytomorphologically classified as uncertain malignant (−UMF) with cytoplasmic positive staining with antibodies against the RCC marker CAIX (A) . Clusters of CNHC-UMF and -BF without reactivity for CAIX antibodies ( B and C , respectively). A single CNHC-MF with positive cytoplasmic (D) and without staining for CAIX (E) . Single CAIX-negative CNHC-UMF and -BF ( F and G , respectively).
    Figure Legend Snippet: Immunocytochemical analysis of CNHCs with antibodies against the RCC marker CAIX. Clusters of CNHCs cytomorphologically classified as uncertain malignant (−UMF) with cytoplasmic positive staining with antibodies against the RCC marker CAIX (A) . Clusters of CNHC-UMF and -BF without reactivity for CAIX antibodies ( B and C , respectively). A single CNHC-MF with positive cytoplasmic (D) and without staining for CAIX (E) . Single CAIX-negative CNHC-UMF and -BF ( F and G , respectively).

    Techniques Used: Marker, Staining

    Related Articles

    Western Blot:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Generated:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Immunoprecipitation:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Luciferase:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Chromatin Immunoprecipitation:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Blocking Assay:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Saline:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Polymer:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Incubation:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Expressing:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Next-Generation Sequencing:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,

    Staining:

    Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis
    Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, NB100-417, Novus Biologicals), HIF1α (1:200, NB100-449, Novus Biologicals), F4/80 (1:200, 14-4801-82, Invitrogen), CD80 (1:200, 14-0081-82, Invitrogen), CD206 (1:200, 141702, Biolegend), CD3 (1:100, 17-0032-80,



    Similar Products

    93
    Bio-Techne corporation human carbonic anhydrase ix/ca9 antibody
    Human Carbonic Anhydrase Ix/Ca9 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/Human+Carbonic+Anhydrase+IX%2FCA9+Antibody/custom%40af2188%4042242232
    Average 93 stars, based on 1 article reviews
    human carbonic anhydrase ix/ca9 antibody - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ca ix
    Ca Ix, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/CA9+Rabbit+mAb/bio_rxiv__64898__2026__11__03__763942-164-2-3
    Average 94 stars, based on 1 article reviews
    ca ix - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    Proteintech ca ix
    Ca Ix, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/CA9+Antibody/10__3390_slash_biomedicines14102336-82-17-19
    Average 95 stars, based on 1 article reviews
    ca ix - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    OriGene caix
    Caix, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/Carbonic+Anhydrase+IX+(CA9)+(NM_001216)+Human+Tagged+ORF+Clone+Lentiviral+Particle/pmc13137485-91-32-33
    Average 94 stars, based on 1 article reviews
    caix - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Cusabio ca9 protein
    GA inhibits TNBC growth via targeting <t>CA9.</t> (a) Venn diagram showing the number of differentially expressed genes in the comparison between MDA-MB-231 and BT549. (b,c) TCGA and GEO databases show that CA9 is highly expressed in TNBC. (d) Correlation analysis between TNBC patient prognosis and CA9 expression. (e) IHC staining of TNBC patient-derived cancer tissue and adjacent tissue. Scale bar: 100 μm. (f) The quantitative analysis of CA9. (g) The protein levels of CA9 in cell lines were measured by Western blotting. (h) The predicted binding mode of GA with CA9. (i) GA binds to CA9 protein as shown by SPR. (j,k) CETSA analysis of CA9 combined with GA. (l,m) CA9 mRNA levels after GA 24 h treatment by qRT-PCR. (n,o) CA9 protein levels after GA 24 h treatment by Western blotting. (p) The related protein levels of siRNA-CA9 TNBC cells after GA 24 h treatment by Western blotting. Data are presented as mean ± SD. n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared with control group.
    Ca9 Protein, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/Recombinant+Human+Carbonic+anhydrase+9(CA9)%2C+partial/pmc13013538-137-1-3
    Average 94 stars, based on 1 article reviews
    ca9 protein - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    Proteintech rabbit anti caix
    GA inhibits TNBC growth via targeting <t>CA9.</t> (a) Venn diagram showing the number of differentially expressed genes in the comparison between MDA-MB-231 and BT549. (b,c) TCGA and GEO databases show that CA9 is highly expressed in TNBC. (d) Correlation analysis between TNBC patient prognosis and CA9 expression. (e) IHC staining of TNBC patient-derived cancer tissue and adjacent tissue. Scale bar: 100 μm. (f) The quantitative analysis of CA9. (g) The protein levels of CA9 in cell lines were measured by Western blotting. (h) The predicted binding mode of GA with CA9. (i) GA binds to CA9 protein as shown by SPR. (j,k) CETSA analysis of CA9 combined with GA. (l,m) CA9 mRNA levels after GA 24 h treatment by qRT-PCR. (n,o) CA9 protein levels after GA 24 h treatment by Western blotting. (p) The related protein levels of siRNA-CA9 TNBC cells after GA 24 h treatment by Western blotting. Data are presented as mean ± SD. n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared with control group.
    Rabbit Anti Caix, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/CA9+Antibody/pm41784166-212-8-10
    Average 95 stars, based on 1 article reviews
    rabbit anti caix - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    Proteintech rabbit antihuman caix primary antibody
    GA inhibits TNBC growth via targeting <t>CA9.</t> (a) Venn diagram showing the number of differentially expressed genes in the comparison between MDA-MB-231 and BT549. (b,c) TCGA and GEO databases show that CA9 is highly expressed in TNBC. (d) Correlation analysis between TNBC patient prognosis and CA9 expression. (e) IHC staining of TNBC patient-derived cancer tissue and adjacent tissue. Scale bar: 100 μm. (f) The quantitative analysis of CA9. (g) The protein levels of CA9 in cell lines were measured by Western blotting. (h) The predicted binding mode of GA with CA9. (i) GA binds to CA9 protein as shown by SPR. (j,k) CETSA analysis of CA9 combined with GA. (l,m) CA9 mRNA levels after GA 24 h treatment by qRT-PCR. (n,o) CA9 protein levels after GA 24 h treatment by Western blotting. (p) The related protein levels of siRNA-CA9 TNBC cells after GA 24 h treatment by Western blotting. Data are presented as mean ± SD. n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared with control group.
    Rabbit Antihuman Caix Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/CA9+Antibody/pm41784166-217-17-25
    Average 95 stars, based on 1 article reviews
    rabbit antihuman caix primary antibody - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    Atlas Antibodies anti ca9
    GA inhibits TNBC growth via targeting <t>CA9.</t> (a) Venn diagram showing the number of differentially expressed genes in the comparison between MDA-MB-231 and BT549. (b,c) TCGA and GEO databases show that CA9 is highly expressed in TNBC. (d) Correlation analysis between TNBC patient prognosis and CA9 expression. (e) IHC staining of TNBC patient-derived cancer tissue and adjacent tissue. Scale bar: 100 μm. (f) The quantitative analysis of CA9. (g) The protein levels of CA9 in cell lines were measured by Western blotting. (h) The predicted binding mode of GA with CA9. (i) GA binds to CA9 protein as shown by SPR. (j,k) CETSA analysis of CA9 combined with GA. (l,m) CA9 mRNA levels after GA 24 h treatment by qRT-PCR. (n,o) CA9 protein levels after GA 24 h treatment by Western blotting. (p) The related protein levels of siRNA-CA9 TNBC cells after GA 24 h treatment by Western blotting. Data are presented as mean ± SD. n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared with control group.
    Anti Ca9, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/Anti-CA9/bio_rxiv__64898__2026__02__26__707379-154-33-35
    Average 94 stars, based on 1 article reviews
    anti ca9 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Novus Biologicals ca9
    GA inhibits TNBC growth via targeting <t>CA9.</t> (a) Venn diagram showing the number of differentially expressed genes in the comparison between MDA-MB-231 and BT549. (b,c) TCGA and GEO databases show that CA9 is highly expressed in TNBC. (d) Correlation analysis between TNBC patient prognosis and CA9 expression. (e) IHC staining of TNBC patient-derived cancer tissue and adjacent tissue. Scale bar: 100 μm. (f) The quantitative analysis of CA9. (g) The protein levels of CA9 in cell lines were measured by Western blotting. (h) The predicted binding mode of GA with CA9. (i) GA binds to CA9 protein as shown by SPR. (j,k) CETSA analysis of CA9 combined with GA. (l,m) CA9 mRNA levels after GA 24 h treatment by qRT-PCR. (n,o) CA9 protein levels after GA 24 h treatment by Western blotting. (p) The related protein levels of siRNA-CA9 TNBC cells after GA 24 h treatment by Western blotting. Data are presented as mean ± SD. n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared with control group.
    Ca9, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ca9/Carbonic+Anhydrase+IX%2FCA9+Antibody+-+BSA+Free/pm41714613-338-2-6
    Average 94 stars, based on 1 article reviews
    ca9 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    GA inhibits TNBC growth via targeting CA9. (a) Venn diagram showing the number of differentially expressed genes in the comparison between MDA-MB-231 and BT549. (b,c) TCGA and GEO databases show that CA9 is highly expressed in TNBC. (d) Correlation analysis between TNBC patient prognosis and CA9 expression. (e) IHC staining of TNBC patient-derived cancer tissue and adjacent tissue. Scale bar: 100 μm. (f) The quantitative analysis of CA9. (g) The protein levels of CA9 in cell lines were measured by Western blotting. (h) The predicted binding mode of GA with CA9. (i) GA binds to CA9 protein as shown by SPR. (j,k) CETSA analysis of CA9 combined with GA. (l,m) CA9 mRNA levels after GA 24 h treatment by qRT-PCR. (n,o) CA9 protein levels after GA 24 h treatment by Western blotting. (p) The related protein levels of siRNA-CA9 TNBC cells after GA 24 h treatment by Western blotting. Data are presented as mean ± SD. n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared with control group.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Garciniagifolone A, derived from Garcinia multiflora fruits, inhibits triple-negative breast cancer cells and organoids growth by targeting CA9

    doi: 10.3389/fcell.2026.1767397

    Figure Lengend Snippet: GA inhibits TNBC growth via targeting CA9. (a) Venn diagram showing the number of differentially expressed genes in the comparison between MDA-MB-231 and BT549. (b,c) TCGA and GEO databases show that CA9 is highly expressed in TNBC. (d) Correlation analysis between TNBC patient prognosis and CA9 expression. (e) IHC staining of TNBC patient-derived cancer tissue and adjacent tissue. Scale bar: 100 μm. (f) The quantitative analysis of CA9. (g) The protein levels of CA9 in cell lines were measured by Western blotting. (h) The predicted binding mode of GA with CA9. (i) GA binds to CA9 protein as shown by SPR. (j,k) CETSA analysis of CA9 combined with GA. (l,m) CA9 mRNA levels after GA 24 h treatment by qRT-PCR. (n,o) CA9 protein levels after GA 24 h treatment by Western blotting. (p) The related protein levels of siRNA-CA9 TNBC cells after GA 24 h treatment by Western blotting. Data are presented as mean ± SD. n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 when compared with control group.

    Article Snippet: The CA9 protein (Cusabio, CSB-EP614990HUc0) was coupled to the surface of CM5 chip biosensor (Cytiva, 29104988) in 10 mM sodium acetate (pH 4.5).

    Techniques: Comparison, Expressing, Immunohistochemistry, Derivative Assay, Western Blot, Binding Assay, Quantitative RT-PCR, Control

    Model of the anti-tumor mechanism of GA in TNBC cells. GA could bind CA9 to induce early stage autophagy by blocking PI3K/AKT/mTOR signaling pathway. Moreover, GA suppressed the autophagic flux and increased the p62 to promote ROS production, which activated NLRP3/caspase-1/GSDMD/caspase-3 related pyroptosis and apoptosis to induce TNBC cells death.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Garciniagifolone A, derived from Garcinia multiflora fruits, inhibits triple-negative breast cancer cells and organoids growth by targeting CA9

    doi: 10.3389/fcell.2026.1767397

    Figure Lengend Snippet: Model of the anti-tumor mechanism of GA in TNBC cells. GA could bind CA9 to induce early stage autophagy by blocking PI3K/AKT/mTOR signaling pathway. Moreover, GA suppressed the autophagic flux and increased the p62 to promote ROS production, which activated NLRP3/caspase-1/GSDMD/caspase-3 related pyroptosis and apoptosis to induce TNBC cells death.

    Article Snippet: The CA9 protein (Cusabio, CSB-EP614990HUc0) was coupled to the surface of CM5 chip biosensor (Cytiva, 29104988) in 10 mM sodium acetate (pH 4.5).

    Techniques: Blocking Assay